BR9806971A - Epìtopes de célula t universal para vacinas anti-malária. - Google Patents

Epìtopes de célula t universal para vacinas anti-malária.

Info

Publication number
BR9806971A
BR9806971A BR9806971-3A BR9806971A BR9806971A BR 9806971 A BR9806971 A BR 9806971A BR 9806971 A BR9806971 A BR 9806971A BR 9806971 A BR9806971 A BR 9806971A
Authority
BR
Brazil
Prior art keywords
universal
cell epitopes
malaria
vaccines
malaria vaccines
Prior art date
Application number
BR9806971-3A
Other languages
English (en)
Inventor
Elizabeth Nardin
Alberto Moreno
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of BR9806971A publication Critical patent/BR9806971A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/822—Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"EPITOPES DE CéLULA T UNIVERSAL PARA VACINAS ANTI-MALáRIA". A presente invenção provê métodos e composições para produzir imunidade protetora contra malária. Em particular, a invenção se relaciona a epítopos de célula T universal que produzem resposta de célula T em indivíduos de antecedentes genéticos diferentes. Composições imunogênicas e vacinas compreendendo epítopos de célula T universal específico de malária são descritos.
BR9806971-3A 1997-01-21 1998-01-21 Epìtopes de célula t universal para vacinas anti-malária. BR9806971A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3391697P 1997-01-21 1997-01-21
PCT/US1998/001527 WO1998031382A1 (en) 1997-01-21 1998-01-21 Universal t-cell epitopes for anti-malarial vaccines

Publications (1)

Publication Number Publication Date
BR9806971A true BR9806971A (pt) 2000-03-14

Family

ID=21873185

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806971-3A BR9806971A (pt) 1997-01-21 1998-01-21 Epìtopes de célula t universal para vacinas anti-malária.

Country Status (13)

Country Link
US (2) US6669945B1 (pt)
EP (1) EP1007081A4 (pt)
JP (1) JP2001509813A (pt)
CN (1) CN1244126A (pt)
AP (1) AP1070A (pt)
AU (1) AU5931698A (pt)
BR (1) BR9806971A (pt)
CA (1) CA2278295A1 (pt)
EA (1) EA002545B1 (pt)
IL (1) IL130917A (pt)
OA (1) OA11185A (pt)
WO (1) WO1998031382A1 (pt)
ZA (1) ZA98477B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672290B1 (fr) * 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
US6669945B1 (en) * 1997-01-21 2003-12-30 New York University Universal T-cell epitopes for anti-malarial vaccines
US6942866B2 (en) * 2000-08-16 2005-09-13 Apovia, Inc. Malaria immunogen and vaccine
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
WO2003072722A2 (en) * 2002-02-21 2003-09-04 Apovia, Inc. IMMUNOGENIC AVIAN HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
EP1930043B8 (de) 2006-12-05 2018-06-27 Löwenstein Medical Technology S.A. Verfahren zur Ermittlung der Konzentration von Sauerstoff in einem Atemgasgemisch
WO2009082440A2 (en) * 2007-12-18 2009-07-02 Vaxinnate Corporation Compositions of toll-like receptor agonists and malaria antigens and methods of use
CN102264381B (zh) 2008-10-01 2014-07-09 美国政府(由卫生和人类服务部的部长所代表) 提供对疟原虫的长效免疫应答的用于疟疾的多组分疫苗
EP2196196A1 (en) * 2008-12-10 2010-06-16 Medipol S.A. Compound, medicament, vaccine composition and nanocapsules
WO2010110931A2 (en) * 2009-03-23 2010-09-30 The Brigham And Women's Hospital, Inc. Glycoconjugate vaccines
US9718729B2 (en) * 2009-05-15 2017-08-01 Owens Corning Intellectual Capital, Llc Biocides for bio-based binders, fibrous insulation products and wash water systems
BR112012007961B1 (pt) 2009-10-09 2019-11-19 Owens Corning Intellectual Capital, Llc composição de ligante aquosa para uso na formação de tapetes de não-tecido e isolantes de fibra de vidro, produto isolante fibroso, tapete não tecido e processo para formar o pr oduto isolante fibroso
CN102781958B (zh) * 2009-12-05 2017-07-11 马尔瓦有限责任公司 基于顶复虫Ferlin、Ferlin样蛋白和其它含有C2结构域的蛋白的疟疾疫苗
EP2694717B1 (en) 2011-04-07 2017-06-28 Cargill, Incorporated Bio-based binders including carbohydrates and a pre-reacted product of an alcohol or polyol and a monomeric or polymeric polycarboxylic acid
WO2012145509A2 (en) 2011-04-19 2012-10-26 The Research Foundation Of State University Of New York Adeno-associated-virus rep sequences, vectors, and viruses
CN106463032B (zh) 2014-03-03 2019-05-31 Vsk电子有限公司 利用方向感应的入侵检测方法及系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812214D0 (en) 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
AU5649290A (en) * 1989-04-12 1990-11-05 New York University Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
US5928902A (en) * 1992-02-27 1999-07-27 Smithkline Beecham Biologicals (S.A.) Hybrid protein between CS from plasmodium and HBsAg
WO1994025071A1 (en) * 1993-05-05 1994-11-10 Keith Rose Polyoxime compounds and their preparation
US6669945B1 (en) * 1997-01-21 2003-12-30 New York University Universal T-cell epitopes for anti-malarial vaccines

Also Published As

Publication number Publication date
EP1007081A4 (en) 2003-05-28
IL130917A (en) 2005-08-31
JP2001509813A (ja) 2001-07-24
US6669945B1 (en) 2003-12-30
EP1007081A1 (en) 2000-06-14
CA2278295A1 (en) 1998-07-23
ZA98477B (en) 1998-10-14
AP9901609A0 (en) 1999-09-30
EA199900627A1 (ru) 2000-02-28
IL130917A0 (en) 2001-01-28
OA11185A (en) 2003-05-14
AU5931698A (en) 1998-08-07
US20050249750A1 (en) 2005-11-10
AP1070A (en) 2002-05-19
WO1998031382A1 (en) 1998-07-23
CN1244126A (zh) 2000-02-09
EA002545B1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
BR9806971A (pt) Epìtopes de célula t universal para vacinas anti-malária.
BR9305711A (pt) Vacina à base de urease contra infecção por helicobacter
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
AU4180296A (en) Adjuvant for a vaccine composition
WO1999055730A3 (en) Polyepitope carrier protein
HK1046016B (zh) 疫苗中的重組脫氧核糖核酸膠原
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
WO1995020660A3 (en) Immunization by inoculation of dna transcription unit
ATE264911T1 (de) Eine universelle immunmodulatorische cytokin- expressierende zelllinie in wartestelling. entsprechende zusammensetzungen und methoden ihrer herstellung und verwendungen
PT1104306E (pt) Composicoes de cpg e adjuvantes de saponina e seus metodos
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
DK0814759T3 (da) Solbeskyttelsespræparat omfattende en blanding af titanoxid- og zinkoxidpartikler, fremgangsmåde til fremstilling af disse og deres anvendelse
PT1154790E (pt) Reforco da actividade bactericida de antigenios contra a neisseria com oligonucleotidos contendo motivos cg
UY24654A1 (es) Composición de vacuna contra la malaria
DE69714011D1 (de) Die erzeugung einer immunantwort gegen erwünschte determinanten
PL328870A1 (en) Parapoxviruses containing strange dna, their production and their application as a vaccine
HUP0100352A2 (hu) Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására
WO2005000884A8 (en) Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
BR9803232A (pt) Vaicna de neospora.
TR200002974T2 (tr) Bruselloza karşı canlı aşı
ATE329615T1 (de) Borrelia burgdorferi bacterin
ES2091159A1 (es) Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.
GEP20053444B (en) Immunogenic Liposome Compositions
AR012896A1 (es) Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori
ATE439857T1 (de) Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements